The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health signs North America manufacturing deal with Agropur

Mon, 24th Jun 2019 07:43

(Sharecast News) - OptiBiotix Health has entered into a manufacturing, supply and distribution agreement with Agropur, it announced on Monday.The AIM-traded firm said the agreement granted Agropur an exclusive license to manufacture, supply and distribute OptiBiotix's 'SlimBiome' weight management technology in the United States, Canada and Mexico.It described Agropur, founded in 1938, as a North American "dairy industry leader" with 8,800 employees and sales of $6.7bn in 2018.It processed more than 6.2 billion litres of milk per year at its 39 plants across North America, and boasted a portfolio of brands and products including Natrel, OKA, Iögo, BiPRO, Agropur Grand Cheddar, Olympic, Farmers, Island Farms, Québon, ISO Chill and Crino.SlimBiome, meanwhile, was OptiBiotix's flagship weight management product, which would be supplied by Agropur's Customs Solutions Group as a specialised functional ingredient.It could be incorporated into a wide range of applications, including human nutrition comprising of food and beverages, dairy, dietary supplements and sports nutrition, with the exception of extruded product in cereal particulates which is a market segment serviced by Cereal Ingredients.OptiBiotix said the deal was a "strategic step" to de-risk its supply chain and extend the market reach of SlimBiome, by adding manufacturing in North America.It said it would extend the commercial opportunity for its patented weight management product into the US weight management market, which was estimated to be worth $72bn in 2019.The company said partnering with an established player with an extensive reach to companies using high-value functional ingredients into their food applications would allow end users to reduce transport and tariff costs, while shortening lead-times and granting them access to Agropur's expert advice and capabilities to create value."We are pleased to announce the signing of a manufacturing and supply agreement with Agropur," said Dr Fred Narbel, the managing director of OptiBiotix's prebiotics division."We chose Agropur due to their world leading expertise in manufacturing and distributing specialty ingredients like SlimBiome® and their reputation for supplying high quality products to the food industry."We believe working with Agropur, and similar partners around the world, provides the best opportunity of increasing our global commercial reach and catering to the growing interest we are seeing in SlimBiome® from partners worldwide."Mike Homewood, vice-president of Agropur's Custom Solutions Group, added that the collaboration with OptiBiotix Health was "well-aligned" with his company's goal to bring innovation to its customers."The manufacturing and supply of SlimBiome is a natural fit within our model of solution-focused ingredients for the food, beverage and nutrition industries. We look forward to collaborating with OptiBiotix Health in the North American market."
More News
9 Dec 2019 11:43

OptiBiotix Inks Distribution Deal For Supplement In Philippines

OptiBiotix Inks Distribution Deal For Supplement In Philippines

Read more
6 Dec 2019 14:01

OptiBiotix signs three new distribution agreements

(Sharecast News) - Life sciences business OptiBiotix Health has entered into three new exclusive distribution agreements, it announced on Friday, in a bid to extend the global reach of its 'SlimBiome' and 'GoFigure' products.

Read more
6 Dec 2019 11:56

OptiBiotix Inks New GoFigure And SlimBiome Product Distribution Deals

OptiBiotix Inks New GoFigure And SlimBiome Product Distribution Deals

Read more
5 Dec 2019 16:37

OptiBiotix Health gets CE-mark for unflavoured 'SlimBiome Medical'

(Sharecast News) - Life sciences business OptiBiotix Health announced on Thursday that it has achieved medical device status and a CE-mark for an unflavoured version of 'SlimBiome Medical'.

Read more
5 Dec 2019 14:08

OptiBiotix Pleased With Latest Medical Device Status, CE Mark Grant

OptiBiotix Pleased With Latest Medical Device Status, CE Mark Grant

Read more
4 Dec 2019 15:28

OptiBiotix Health appoints ProBiotix sales manager for Europe

(Sharecast News) - Life sciences business OptiBiotix Health announced the appointment of Mikkel Hvid-Hansen as the European sales leader of its wholly-owned subsidiary ProBiotix Health.

Read more
9 Oct 2019 10:12

OptiBiotix granted two key certifications for 'LPLDL'

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its fully-owned subsidiary, ProBiotix Health, has completed process validation under 'Pharmaceutical Good Manufacturing Practices' (GMP) for its 'LPLDL' product as a drug substance.

Read more
9 Oct 2019 08:57

OptiBiotix's LPLDL Gets Generally Recognized As Safe Status In US

OptiBiotix's LPLDL Gets Generally Recognized As Safe Status In US

Read more
28 Aug 2019 10:37

WINNERS & LOSERS SUMMARY: BP Up As Alaskan Sale Paves Way For Payouts

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------BP, up

Read more
28 Aug 2019 10:16

OptiBiotix Interim Loss Widens As Commercial Transition Into Continues

(Alliance News) - OptiBiotix Health PLC on Wednesday reported a widened in loss in the first half of its financial year, as the company said it continues its transition from a research & firm

Read more
11 Jul 2019 12:15

OptiBiotix Partners With US Company On Pharmaceutical Drug Product

(Alliance News) - OptiBiotix Health PLC on Thursday said it has signed an agreement with an undisclosed US partner to develop its LPLDL strain of bacteria as a pharmaceutical drug in OptiBiotix at

Read more
1 Jul 2019 12:16

OptiBiotix Inks Licence Agreement For LPLDL With Kappa Bioscience

(Alliance News) - OptiBiotix Health PLC on Monday said it has signed a licence agreement with Kappa Bioscience AS covering Lactobacillus plantarum LPLDL in cardiovascular health.The is for

Read more
4 Jun 2019 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 5 JuneFunding Circle HoldingsGVC HoldingsAAFlowtech 6 Bank (combination (re

Read more
20 May 2019 10:45

OptiBiotix inks deal with Nutrilinea for hypertension supplement

(Sharecast News) - Life sciences company OptiBiotix Health announces on Monday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Nutrilinea for the use of its 'LPLDL' product in a food supplement for the reduction of high blood pressure, or hypertension.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.